Clinical Trials

Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas

Assessing Brain Metabolism Using MRS With Deuterated Glucose

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Risk Factors in Tachycardiomyopathy

Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma

Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)

A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin

Acceptance-based Care for Child Eating and Physical Activity Treatment

Allogeneic Neuroblastoma Cells for Relapsed/ Refractory Neuroblastoma, CYCHEALL

Better Together Physician Coaching to Mitigate Burnout in Male-Identifying Trainees

Better Together Physician Coaching: Mitigating Burnout in UME

Chart Review of Patients Undergoing Ketamine Infusions

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME

Continuous Erector Spinae Block for Post Analgesia in Pediatric Patients

Delayed Educational Reminders in Acute Myocardial Infarction (MI)

Different Frailty Scores to Incidence of Post-operative Delirium and Cognitive Dysfunction

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases

Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)